Your cart is empty.
Männedorf, Switzerland, October 30, 2012 – Tecan and TAP Biosystems, a leading supplier of innovative cell culture systems, have announced a comarketing agreement to further expand the automated 3D cell culture capabilities of the Freedom EVO® liquid handling platform. Automation of TAP’s collagen-based RAFT™ cell culture system will allow scientists to quickly and conveniently create 3D cell cultures in a 96-well, SBSformat.
The RAFT 3D cell culture system uses biologically relevant concentrations of collagen matrix to ensure cells grow and proliferate in an environment closely resembling the native tissue. The Freedom EVO workstation is configured with a number of modules, including reagent and microplate cooling units and a heated shaking device, to provide fully automated preparation and maintenance of RAFT cell cultures. This ensures rapid, reliable creation of consistent and reproducible 3D cell cultures, offering walkaway processing for a wide range of cell biology applications.
Kevin Moore, Head of Applications and Solutions at Tecan, commented: “We are pleased to further expand our automated 3D cell culture portfolio to include the RAFT system. Working together with TAP Biosystems, we will be able to offer a complete solution for automated 3D cell culture.”
Dr Grant Cameron, TAP Biosystems’ RAFT Development Director, added: “RAFT is rapidly becoming a core secondary screening technology within drug discovery. This exciting collaboration will enable researchers to expand the power of the realistic collagen environment of RAFT, with substantially increased throughput to meet their cell-based screening requirements.”
To find out more about Tecan’s 3D cell culture solutions, visit www.tecan.com/3Dcellculture
To find out more about the RAFT cell culture system, visit www.raft3dcellculture.com
Tecan Trading AG
Cornelia Kegele, Antonietta Allocca
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2011, Tecan generated sales of CHF 377 million (USD 424 million; EUR 306 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Swiss security number: 1210019).
TAP Biosystems (the new corporate identity of The Automation Partnership) provides innovative automation systems and consumables to improve productivity in life science research, development and production. For over 20 years TAP Biosystems has been the leader in the design and development of automated cell culture and processing systems with applications in bioprocessing, drug discovery and regenerative medicine. Systems include ambr, CompacT SelecT, Fill-It and RAFT.
TAP Biosystems is a privately-owned company with headquarters near Cambridge, UK and a sales and support facility near Wilmington, Delaware, USA.www.tapbiosystems.com